United Capital Financial Advisors LLC Invests $2.58 Million in Humana Inc. $HUM

United Capital Financial Advisors LLC purchased a new stake in shares of Humana Inc. (NYSE:HUM) during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 6,495 shares of the insurance provider’s stock, valued at approximately $2,580,000.

Other large investors have also recently bought and sold shares of the company. Wilkerson Advisory Group LLC grew its stake in Humana by 24.6% during the 2nd quarter. Wilkerson Advisory Group LLC now owns 167 shares of the insurance provider’s stock valued at $66,000 after acquiring an additional 33 shares in the last quarter. Bogart Wealth LLC lifted its position in shares of Humana by 192.0% in the second quarter. Bogart Wealth LLC now owns 73 shares of the insurance provider’s stock worth $29,000 after purchasing an additional 48 shares in the last quarter. Fiduciary Alliance LLC boosted its holdings in shares of Humana by 0.9% during the first quarter. Fiduciary Alliance LLC now owns 5,628 shares of the insurance provider’s stock worth $976,000 after purchasing an additional 49 shares during the period. Sanctuary Advisors LLC boosted its holdings in shares of Humana by 1.6% during the fourth quarter. Sanctuary Advisors LLC now owns 3,389 shares of the insurance provider’s stock worth $868,000 after purchasing an additional 52 shares during the period. Finally, Horizon Investments LLC grew its position in Humana by 2.5% during the fourth quarter. Horizon Investments LLC now owns 2,236 shares of the insurance provider’s stock valued at $573,000 after purchasing an additional 55 shares in the last quarter. 92.38% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of equities research analysts have issued reports on the stock. Morgan Stanley upgraded shares of Humana from an “underweight” rating to an “equal weight” rating and increased their target price for the stock from $249.00 to $370.00 in a research report on Tuesday, August 4th. Oppenheimer restated an “outperform” rating and set a $405.00 price target on shares of Humana in a report on Thursday, July 30th. Robert W. Baird set a $390.00 price target on shares of Humana in a research note on Thursday, July 30th. Bank of America upgraded Humana from a “neutral” rating to a “buy” rating and set a $500.00 price objective for the company in a report on Wednesday, July 29th. Finally, TD Cowen boosted their target price on Humana from $350.00 to $370.00 and gave the company a “hold” rating in a research note on Friday, July 31st. Fourteen analysts have rated the stock with a Buy rating, fifteen have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $403.91.

Humana Price Performance

NYSE HUM opened at $386.92 on Friday. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.62. The stock has a market capitalization of $46.46 billion, a PE ratio of 36.61, a price-to-earnings-growth ratio of 2.24 and a beta of 0.72. Humana Inc. has a 12-month low of $163.11 and a 12-month high of $428.88. The company has a 50 day moving average price of $385.60 and a two-hundred day moving average price of $288.47.

Humana (NYSE:HUM) last announced its quarterly earnings results on Wednesday, July 29th. The insurance provider reported $7.61 EPS for the quarter, topping the consensus estimate of $7.27 by $0.34. Humana had a net margin of 0.88% and a return on equity of 11.20%. The company had revenue of $40.89 billion for the quarter, compared to analyst estimates of $40.58 billion. During the same quarter in the prior year, the business posted $6.27 EPS. Humana’s quarterly revenue was up 26.2% on a year-over-year basis. As a group, equities analysts predict that Humana Inc. will post 9.12 earnings per share for the current fiscal year.

Humana Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.